Trade MiMedx Group Inc - MDXG CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 9.14 |
Open | 9.19 |
1-Year Change | 13.32% |
Day's Range | 9.06 - 9.32 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 21, 2025 | 9.12 | 0.05 | 0.55% | 9.07 | 9.34 | 9.06 |
Jan 17, 2025 | 9.10 | 0.09 | 1.00% | 9.01 | 9.14 | 8.96 |
Jan 16, 2025 | 9.05 | 0.44 | 5.11% | 8.61 | 9.09 | 8.61 |
Jan 15, 2025 | 8.78 | 0.23 | 2.69% | 8.55 | 8.83 | 8.55 |
Jan 14, 2025 | 8.58 | 0.18 | 2.14% | 8.40 | 8.63 | 8.40 |
Jan 13, 2025 | 8.53 | 0.03 | 0.35% | 8.50 | 8.70 | 8.47 |
Jan 10, 2025 | 8.61 | -0.03 | -0.35% | 8.64 | 8.71 | 8.51 |
Jan 8, 2025 | 8.82 | 0.14 | 1.61% | 8.68 | 8.94 | 8.68 |
Jan 7, 2025 | 8.76 | -0.14 | -1.57% | 8.90 | 8.99 | 8.68 |
Jan 6, 2025 | 8.87 | -0.29 | -3.17% | 9.16 | 9.23 | 8.78 |
Jan 3, 2025 | 9.15 | -0.11 | -1.19% | 9.26 | 9.33 | 9.07 |
Jan 2, 2025 | 9.26 | -0.36 | -3.74% | 9.62 | 9.68 | 9.26 |
Dec 31, 2024 | 9.60 | 0.12 | 1.27% | 9.48 | 9.62 | 9.31 |
Dec 30, 2024 | 9.46 | 0.18 | 1.94% | 9.28 | 9.54 | 9.27 |
Dec 27, 2024 | 9.40 | 0.20 | 2.17% | 9.20 | 9.40 | 9.03 |
Dec 26, 2024 | 9.36 | 0.28 | 3.08% | 9.08 | 9.39 | 9.03 |
Dec 24, 2024 | 9.06 | -0.16 | -1.74% | 9.22 | 9.28 | 9.06 |
Dec 23, 2024 | 9.25 | 0.22 | 2.44% | 9.03 | 9.28 | 8.95 |
Dec 20, 2024 | 9.08 | 0.17 | 1.91% | 8.91 | 9.20 | 8.85 |
Dec 19, 2024 | 9.06 | -0.06 | -0.66% | 9.12 | 9.19 | 8.96 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
MiMedx Company profile
About MiMedx Group Inc
MiMedx Group, Inc. is utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing the needs of patients with acute and chronic non-healing wounds, and a late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company’s platform technologies include AmnioFix, EpiFix, EpiCord, AmnioCord and AmnioFill. Its AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. The EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. Its AmnioFill is a particulate product comprised of placental connective tissue matrix, derived from the placental disc and placental membranes.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, MiMedx Group Inc revenues increased 4% to $258.6M. Net loss applicable to common stockholders decreased 80% to $16.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Investigation, restatement and related decrease of 94% to $3.8M (expense), Loss on extinguishment of debt decrease from $8.2M (expense) to
Equity composition
Common Stock $.001 Par, 03/11, 100M auth., 64,331,910 issd., less 50,000 shs. in Treas. @ $25K. Insiders own approx. 18.35%.
Industry: | Bio Medical Devices |
1775 W Oak Commons Court, Ne
MARIETTA
GEORGIA 30062
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com